Table 2.
Outcomes after Apixaban initiation
| Outcomes | Case #1 | Case #2 | Case #3 | Case #4 |
|---|---|---|---|---|
| Major bleeding | No | No | No | No |
| Minor bleeding | No | No | No | No |
| Hospital admission within 6 months of apixaban initiation | Yes | Yes | No | Yes |
| Hospital admission within 12 months of apixaban initiation | Yes | Yes | No | Yes |
| New stroke within 6 months of apixaban initiation | No | No | No | No |
| Any new stroke after apixaban initiation | No | No | No | No |
| New VTE within 6 months of Apixaban initiation | No | No | No | No |
| Any new VTE after Apixaban initiation | No | No | Yes (PE) | No |
| Any new thrombosis after apixaban initiation | No | No | Yes (PE) | No |
| Switched to other anticoagulants (eg, warfarin) | No | No | Yes (Warfarin) | No |